Join George Portugal, PhD for an overview of microelectrode array (MEA) technology used for cardiac research and some best practices for integrating this technique into your research.
Microelectrode array (MEA) technology is a valuable tool for research using stem cell derived or primary cardiomyocytes. Networks of extracellular recording electrodes can allow investigators to rapidly screen compounds, monitor for toxicological effects, and study changes in conduction velocity or arrhythmia. Furthermore, this technology can also be applied to study changes in organoid, cardiac slice, or whole heart applications.
In this presentation, George discusses some of the methodological challenges to consider when using MEA technology for cardiac research. The discussion includes best practices to use with MEA recording and provides examples of recordings using cell culture, slice, and whole heart. Together, these methods can optimize MEA recording and allow it to be easily integrated as a new technique in the lab.
Senior Applications Scientist
Harvard Bioscience, Inc.